Adam Grippin

机构：The University of Texas MD Anderson Cancer Center, Cancer Research Center, MD Anderson Cancer Center Madrid · ORCID：0000-0002-8076-4240

发表论文 151 篇 · 总被引 2120 次 · h-index 22

代表论文

• SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade (2025 · Nature · 被引 108)
• Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial (2025 · The Lancet · 被引 34)
• Nanotechnology for immuno-oncology (2025 · Nature Cancer · 被引 28)
• Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading (2025 · Nature Biomedical Engineering · 被引 24)
• A Generative Artificial Intelligence Copilot for Biomedical Nanoengineering (2025 · ACS Nano · 被引 18)
• 419 SARS-CoV-2 mRNA vaccines sensitize immunologically ‘cold’ tumors to immune checkpoint blockade (2025 · Regular and Young Investigator Award Abstracts · 被引 10)